Onwordi, Ellis Chika
Halff, Els F. http://orcid.org/0000-0001-5814-0899
Whitehurst, Thomas
Mansur, Ayla
Cotel, Marie-Caroline
Wells, Lisa
Creeney, Hannah
Bonsall, David
Rogdaki, Maria http://orcid.org/0000-0003-2685-1789
Shatalina, Ekaterina
Reis Marques, Tiago
Rabiner, Eugenii A.
Gunn, Roger N.
Natesan, Sridhar http://orcid.org/0000-0001-7499-1714
Vernon, Anthony C. http://orcid.org/0000-0001-7305-1069
Howes, Oliver D.
Funding for this research was provided by:
RCUK | Medical Research Council
Article History
Received: 27 June 2019
Accepted: 9 December 2019
First Online: 14 January 2020
Competing interests
: A.M., L.W., D.B., E.A.R. and R.N.G. are employees of Invicro LLC. R.N.G. is a consultant for AbbVie, Biogen & Cerveau. O.D.H. has received investigator-initiated research funding from and/or participated in advisory/speaker meetings organised by Angellini, Astra-Zeneca, Autifony, Biogen, BMS, Eli Lilly, Heptares, Jansenn, Lundbeck, Lyden-Delta, Otsuka, Servier, Sunovion, Rand and Roche. Neither O.D.H. nor his family have been employed by or have holdings/a financial stake in any pharmaceutical company. The other authors declare no competing interests.